Agios Announces Clinical Proof-of-Concept Has Been Established in Phase 1 Study of Mitapivat,...
The Investor Relations website contains information about Agios Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
investor.agios.com